We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current REGN market cap is 97.64B. The company's latest EPS is USD 36.0198 and P/E is 24.68.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.42B | 3.16B | 3.16B | 3.36B | 3.43B |
| Operating Income | 1.05B | 946.7M | 1.02B | 1.11B | 972.9M |
| Net Income | 1.2B | 817.8M | 968.4M | 1.01B | 1.16B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
| Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
| Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 29.21B | 30.06B | 30.66B | 32.16B | 33.08B |
| Total Liabilities | 6.55B | 6.56B | 6.64B | 7.26B | 7.11B |
| Total Equity | 22.66B | 23.5B | 24.02B | 24.9B | 25.97B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B |
| Total Liabilities | 3.72B | 6.14B | 6.67B | 6.55B | 7.11B |
| Total Equity | 11.09B | 11.03B | 18.77B | 22.66B | 25.97B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 5.01B | 1.37B | 2.39B | 3.5B | 4.59B |
| Investing | -3.78B | -235.7M | -2.62B | -3.12B | -3.19B |
| Financing | -1.01B | -322.5M | -936.7M | -1.34B | -1.79B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.43B | 2.62B | 7.08B | 5.01B | 4.59B |
| Investing | -2.03B | -70.6M | -5.38B | -3.78B | -3.19B |
| Financing | -252.1M | -1.97B | -1.01B | -1.01B | -1.79B |
| Market Cap | 97.64B |
| Price to Earnings Ratio | 24.68 |
| Price to Sales Ratio | 7.44 |
| Price to Cash Ratio | 35.74 |
| Price to Book Ratio | 3.76 |
| Dividend Yield | - |
| Shares Outstanding | 109.76M |
| Average Volume (1 week) | 404.62k |
| Average Volume (1 Month) | 448.43k |
| 52 Week Change | 11.08% |
| 52 Week High | 998.325 |
| 52 Week Low | 684.805 |
| Spread (Intraday) | 1.12 (0.13%) |
| Company Name | Regeneron Pharmaceuticals Inc |
| Address |
28 liberty street new york, new york 10005 |
| Website | https://www.regeneron.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
